Janssen nasal spray is recognized in the US as a stand-alone treatment for depression

Spravato, the nasal spray from Janssen Pharmaceutica – a subsidiary of Johnson & Johnson – can now be sold in the United States as a stand-alone treatment for depression. The spray contains esketamine, a relative of the anesthetic drug ketamine, and is only administered under medical supervision if other treatments for depression have not helped.

ttn-3